Virtual Medicinal Product (VMP) - Meningococcal oligosaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Meningococcal oligosaccharide A, C, W135 and Y conjugate vaccine powder and solvent for solution for injection 0.5ml vials Start Date 01-07-2021 End Date
Previous Name Previous Name Meningococcal oligosaccharide A, C, W135 and Y vaccine powder and solvent for solution for injection 0.5ml vials Start Date 11-10-2010 End Date 30-06-2021
Abbreviated Name Abbreviated Name Meningococcal oligosaccharide A, C, W135 and Y conj vacc inj Start Date 01-07-2021
Previous Abbreviated Name Meningococcal oligosaccharide A, C, W135 and Y vacc inj Previous Start Date 08-04-2013 Previous End Date 14-06-2021

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
0.5
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intramuscular
Form
Powder and solvent for solution for injection
Ontology Form/Route
solutioninjection.intramuscular
Name Basis
Other

Codes

ATC Code
J07AH08
BNF Start Date End Date
Current BNF 14040000 Start Date 04-04-2022 End Date
Previous BNF 14040000 Start Date 05-11-2010 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
17192211000001101 29-04-2010

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Meningococcal group A oligosaccharide protein conjugate
Meningococcal group C oligosaccharide protein conjugate
Meningococcal group W135 oligosaccharide protein conjugate
Meningococcal group Y oligosaccharide protein conjugate

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial 3000 Part VIIIA Category C